TYBR Health
PrivateLast Round
Seed
Jan 31, 2025
Est. Valuation
$17M
Total Funding Raised
$2.55M
Momentum Score
50 /100
Company Overview
TYBR Health is a medical device and regenerative medicine company founded in 2020 and based in Houston, Texas. The company develops solutions to improve post-operative recovery by protecting healing tissues and preserving function. Its lead product, the B3 GEL™ System, is a bioresorbable, flowable gel barrier made from a naturally derived extracellular matrix. This gel is designed to be applied during surgery to reduce scarring and adhesions in soft tissues like tendons and ligaments. The company received FDA 510(k) clearance for the B3 GEL™ System in June 2025 and is preparing for a commercial launch by the end of 2025. TYBR Health is backed by investors including Y Combinator.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TYBR Health Comps
Public and private peers based on sector, stage, and business model.
TYBR Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 31, 2025 | ||||
| Accelerator | May 29, 2024 | ||||
| Seed | Mar 29, 2022 | ||||
| Grant | Aug 11, 2021 | ||||
| Seed | Dec 9, 2020 |
Key People
Founding team and executive leadership
TYBR Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Seed, Accelerator |
| Asymmetry Ventures | Seed |
| Y Combinator | Seed |
| VentureSouq | Seed |
| Mayo Clinic Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Jeff Tyber appointed to the Board of Directors.
- Jan 8, 2026
Announced a pre-money valuation of $9.66 million.
TYBR Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TYBR Health's valuation, stock price, and market status.
